Pricing Log in Create free account
Friday 6 November 2026 Export BLLN’s income statement to Excel — free account

BillionToOne, Inc.

BLLN Healthcare Diagnostics & Research

BillionToOne, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $305.1 million, up 100.0% from fiscal 2024.

Revenue
+47.2%
EPS
+164.3%
Free cash flow
+9.25%
Total debt
+60.6%

Quarter to September 2026, against a year earlier

110.53 1.86 −1.65%
Market cap
$5.3B
P/E
88.7×
Fwd P/E
146×
Dividend yield
—
F-score
n/a
Altman Z
6.04
Beneish M
−2.03
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

BillionToOne, Inc. (BLLN) Free cash flow

Alert me on Free cash flow

BillionToOne, Inc.'s free cash flow for fiscal 2025 was $15.7M, compared with −$46.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $33.9M. BillionToOne, Inc. ranks 21st of 49 Diagnostics & Research companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $15.7M —
FY2024 −$46.8M —
FY2023 −$59.8M —

Quarterly newest first

Period Free cash flow Change
Sep 2026 $8.6M 69.08%
Jun 2026 $5.1M (53.58%)
Mar 2026 $11.0M 18.41%
Dec 2025 $9.3M 17.55%
6 more quarters

Free cash flow against peers

Company Free cash flow
QGEN QIAGEN N.V. compare $440.6M
VCYT Veracyte, Inc. compare $161.9M
SHC Sotera Health Company compare $135.4M
RDNT RadNet, Inc. compare $74.4M
CDNA CareDx, Inc. compare $59.8M
BLLN BillionToOne, Inc. $33.9M
ADPT Adaptive Biotechnologies Corporation compare −$8.8M
NEO NeoGenomics, Inc. compare −$26.5M
GRAL GRAIL, Inc. compare −$312.0M

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on BLLN